Fortress Biotech (FBIO) EPS (Weighted Average and Diluted): 2018-2025
Historic EPS (Weighted Average and Diluted) for Fortress Biotech (FBIO) over the last 5 years, with Sep 2025 value amounting to $0.11.
- Fortress Biotech's EPS (Weighted Average and Diluted) rose 114.47% to $0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.18, marking a year-over-year increase of 94.12%. This contributed to the annual value of -$2.69 for FY2024, which is 68.24% up from last year.
- Per Fortress Biotech's latest filing, its EPS (Weighted Average and Diluted) stood at $0.11 for Q3 2025, which was down 75.56% from $0.45 recorded in Q2 2025.
- Fortress Biotech's EPS (Weighted Average and Diluted)'s 5-year high stood at $0.45 during Q2 2025, with a 5-year trough of -$4.82 in Q4 2022.
- In the last 3 years, Fortress Biotech's EPS (Weighted Average and Diluted) had a median value of -$0.53 in 2023 and averaged -$0.73.
- Per our database at Business Quant, Fortress Biotech's EPS (Weighted Average and Diluted) plummeted by 1,480.77% in 2022 and then soared by 161.64% in 2025.
- Fortress Biotech's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.38 in 2021, then plummeted by 1,168.42% to -$4.82 in 2022, then skyrocketed by 89.00% to -$0.53 in 2023, then soared by 50.94% to -$0.26 in 2024, then soared by 114.47% to $0.11 in 2025.
- Its last three reported values are $0.11 in Q3 2025, $0.45 for Q2 2025, and -$0.48 during Q1 2025.